Margaret Fettis-Koenders

Margaret Fettis-Koenders is a Senior Scientist at AbbVie, specializing as a Conjugation Chemist within the Therapeutic Platform Chemistry, Bioconjugation, and Technology sectors since April 2020. With expertise in antibody drug conjugate (ADC) technology, Margaret collaborates across diverse applications in Discovery Biology, Immunology, Oncology, and Neuroscience. Previously, Margaret served as a Postdoctoral Fellow at Georgia Institute of Technology, focusing on mechanobiology and immunoengineering, and earned a Ph.D. in Biomedical Engineering from the University of Florida. Earlier research roles include a Technical Associate position at the University of Rochester Medical Center, where Margaret investigated T cell signaling and activation, and undergraduate research in neurobiology at the University of Chicago. Margaret's robust skillset encompasses protein engineering, biomaterial functionalization, microfluidics, and multiple advanced laboratory techniques.